Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Belumosudil for graft versus host disease	Belumosudil (SLx-2119; KD025; KD-025)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Belzutifan for advanced or metastatic clear cell renal cell carcinoma after 1 therapy	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Renal Cancer	2022	View \| Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Genetic Disorders , Oncology , Renal Cancer	2021	View \| Download
Belzutifan with Lenvatinib in Patients with Advanced Renal Cell Carcinoma	Belzutifan (PT2977; MK-6482) , Lenvatinib (Kisplyx; E7080; lenvatinib mesilate)	Renal cell carcinoma (RCC)	Renal Cancer	2024	View \| Download
Bemarituzumab with chemotherapy for previously untreated advanced gastric or gastroesophageal junction cancer	Bemarituzumab (FPA-144;AMG 552)	Gastric cancer , Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2024	View \| Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia in patients unable to reach cholesterol goals with the maximum tolerated dose of a statin	Bempedoic acid (ETC-1002; Nilemdo)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempegaldesleukin in combination with nivolumab for previously untreated unresectable or metastatic melanoma	Bempegaldesleukin (NKTR-214; BMS-986321; NEKTAR) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Melanoma	Skin Cancer	2022	View \| Download
Benegrastim for treating chemotherapy-induced neutropenia in women with breast cancer	Benegrastim	Breast cancer	Breast Cancer , Immunology , Toxicology	2022	View \| Download